Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
Non-small cell lung cancer is recognized as the deadliest cancer across the globe. In some areas, it is more common in women than even breast and cervical cancer. Its rise, vaulted by smoking habits and increasing air pollution, has garnered much attention and resource in the medical field. The firs...
Guardado en:
Autores principales: | Wenxiao Jiang, Guiqing Cai, Peter Hu, Yue Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8201e3885f3f42649a3d9af8a4a8c852 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical applications of pharmacogenomics
por: Quiñones,Luis, et al.
Publicado: (2017) -
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
por: Michelle Liu, et al.
Publicado: (2021) -
The pharmacogenomics journal
Publicado: (2001) -
Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
por: Venkatachalapathy P, et al.
Publicado: (2021) -
Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
por: Damian Mojsak, et al.
Publicado: (2021)